| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
CareDx (NASDAQ:CDNA) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
CareDx beat estimated earnings by 37.0%, reporting an EPS of $-0.17 versus an estimate of $-0.27.
Revenue was down $16.82 million from the same period last year.
Last quarter the company beat on EPS by $0.21 which was followed by a 14.000000000000002% increase in the share price the next day.
Here's a look at CareDx's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.39 | -0.31 | -0.11 | -0.09 |
| EPS Actual | -0.18 | -0.18 | -0.11 | -0.07 |
| Revenue Estimate | 53.14M | 61.76M | 80.70M | 81.66M |
| Revenue Actual | 67.19M | 70.30M | 77.26M | 82.38M |
To track all earnings releases for CareDx visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CDNA
